Randomised double blind trial investigating effects of nicotine and atomoxetine on brain function during response inhibition
Latest Information Update: 16 Jan 2019
At a glance
- Drugs Atomoxetine (Primary) ; Nicotine (Primary) ; Mannitol; Silicon-dioxide
- Indications Attention-deficit hyperactivity disorder; Parkinson's disease
- Focus Therapeutic Use
Most Recent Events
- 16 Jan 2019 New trial record
- 12 Dec 2018 Results published in the European Neuropsychopharmacology